Pacira BioSciences
PCRX
PCRX
226 hedge funds and large institutions have $1.58B invested in Pacira BioSciences in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 82 increasing their positions, 72 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 231 → 226 (-5)
23% less call options, than puts
Call options by funds: $8.82M | Put options by funds: $11.5M
23% less capital invested
Capital invested by funds: $2.06B → $1.58B (-$483M)
Holders
226
Holding in Top 10
4
Calls
$8.82M
Puts
$11.5M
Top Buyers
| 1 | +$54.6M | |
| 2 | +$22.5M | |
| 3 | +$11.2M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$8.68M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$7.73M |
Top Sellers
| 1 | -$12.2M | |
| 2 | -$9.05M | |
| 3 | -$8.38M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$7.35M |
| 5 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$6.75M |